Symbols

BBIO

BridgeBio Pharma·NASDAQ

--(--)

Market Open: --

--(--)

Pre-Market: --

BBIO Profile

Bridgebio Pharma, Inc.

A commercial-stage biopharmaceutical company focused on genetic diseases and cancers

Industry

Biological Technology

Established Date

05/17/2019

Listing Date

06/27/2019

Exchange

NASDAQ Stock Exchange

Full-time Employees

725

Fiscal Year Ends

12-31

Website

bridgebio.com

Security Type

Common stock

Office address

3160 Porter Drive, Suite 250, Palo Alto, CA 94304

Business

Introduction

BridgeBio Pharma, Inc., was incorporated in Delaware on May 17, 2019. The Company is a commercial-stage biopharmaceutical company that aims to discover, create, test and deliver transformative medicines to treat patients with hereditary diseases and cancers with clear genetic drivers.